USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medicalip Co., Ltd.

USPTO PatentsView assignee record - 113 granted patents across 30 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

113

Total patents granted

CPC technology areas

19.0

Avg claims per patent

+5%

5-year filing velocity

The verdict

Medicalip holds 113 US patents across 30 technology areas, rank #3,307 of 50,000 tracked assignees.

#3,307
of 50,000 US assignees by volume: Top 8%
by Innovation Score (53.8/100): 19.0
avg claims per patent: +5%
filing velocity, last 5 yrs

Portfolio overview

Medicalip Co., Ltd. has been granted 113 US utility patents between 2015 and 2025, placing Medicalip Co., Ltd. at rank #3,307 across all assignees tracked by PlainPatent. This portfolio spans 30 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.0 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, Medicalip Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Medicalip sits between Golba Llc (113 patents, rank #3,303) and Rothy's, Inc (113 patents, rank #3,311) - the closest US assignees by grant volume. The composite Innovation Score of 53.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 58 grants, compared with 55 in the 2015–2019 window, a +5% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Medicalip Co., Ltd.'s 19.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 30 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medicalip Co., Ltd. against peers pursuing similar technology classes.

Golba

113
Georgia State Uni…

113
Idemia France

113
Kanzaki Kokyukoki…

113
Mikuni

113
Panasonic I-pro S…

113
Pass & Seymour

113
Rothy's

113
Medicalip ◀

113

What this shows Medicalip holds 113 patents at rank #3,307, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medicalip

By rank, the assignees closest to #3,307 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in Medicalip's primary technology class.

Medicalip's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Medicalip Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	11	9.7%
2016	8	7.1%
2017	13	11.5%
2018	5	4.4%
2019	18	15.9%
2020	6	5.3%
2021	12	10.6%
2022	13	11.5%
2023	17	15.0%
2024	6	5.3%
2025	4	3.5%

Which technologies does Medicalip Co., Ltd. patent most?

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 31

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 28

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 26

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 21

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 20

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 19

C07K - PEPTIDES 16

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 12

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 8

C12Y - ENZYMES 7

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 7

A61C - DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE 7

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 6

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 6

G06F - ELECTRIC DIGITAL DATA PROCESSING 6

Top 15 of 30 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#3,307

Across all tracked assignees

Innovation Score

53.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Medicalip Co., Ltd. hold?

Medicalip Co., Ltd. holds 113 US granted patents filed between 2015 and 2025, spanning 30 technology areas.

What is Medicalip Co., Ltd.'s Innovation Score?

Medicalip Co., Ltd. has an Innovation Score of 53.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medicalip Co., Ltd. focus on?

Medicalip Co., Ltd.'s top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 31 patents. The company has filed patents in 30 CPC subclasses total.

Is Medicalip Co., Ltd.'s patent filing rate increasing or decreasing?

Medicalip Co., Ltd.'s recent filing velocity is +5% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Medicalip Co., Ltd.'s patents?

Medicalip Co., Ltd.'s patents average 19.0 claims each. This falls within the standard range, providing solid legal coverage.

How is the Medicalip Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Medicalip's 113 grants land it in the top 8% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Medicalip ranks #3,307 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.